Financials Nanjing Medlander Medical Technology Co.,Ltd.

Equities

688273

CNE100005PV8

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 03:30:00 22/05/2024 am IST 5-day change 1st Jan Change
24.05 CNY +0.92% Intraday chart for Nanjing Medlander Medical Technology Co.,Ltd. +0.71% -27.80%

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 3,260 2,403 2,403 -
Enterprise Value (EV) 1 3,260 3,352 2,403 2,403
P/E ratio 22 x 37.1 x 14.4 x 10.5 x
Yield - 1.8% 2.49% 2.7%
Capitalization / Revenue - 9.83 x 4.23 x 3.33 x
EV / Revenue - 9.83 x 4.23 x 3.33 x
EV / EBITDA - 28.4 x 12.1 x 8.74 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - 2.49 x 1.63 x 1.47 x
Nbr of stocks (in thousands) 1,00,000 1,00,620 1,00,620 -
Reference price 2 32.60 24.05 24.05 24.05
Announcement Date 26/02/23 23/02/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 340.8 568 722
EBITDA 1 - 118 199 275
EBIT 1 - 102.5 199 270
Operating Margin - 30.07% 35.04% 37.4%
Earnings before Tax (EBT) 1 - 101.5 199 270
Net income 1 123 89.82 168 231
Net margin - 26.35% 29.58% 31.99%
EPS 2 1.480 0.8982 1.670 2.300
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - 0.6000 0.6000 0.6500
Announcement Date 26/02/23 23/02/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - 6.63% 11.4% 14%
ROA (Net income/ Total Assets) - 5.8% 10% 12.2%
Assets 1 - 1,549 1,680 1,893
Book Value Per Share 2 - 13.40 14.70 16.40
Cash Flow per Share 2 - 1.360 1.660 2.950
Capex 1 - 74.6 11 11
Capex / Sales - 21.88% 1.94% 1.52%
Announcement Date 26/02/23 23/02/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
24.05
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688273 Stock
  4. Financials Nanjing Medlander Medical Technology Co.,Ltd.